WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Stock Ownership - Who owns Heron Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Heron Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ira DuarteEVP Chief Financial Officer2024-04-191,122$2.64
$2.96kSell
Lisa PerazaVP Chief Accounting Officer2024-01-13756$2.15
$1.63kSell
William P. ForbesEVP Chief Development Officer2023-11-1725,000$1.09
$27.25kBuy
Craig A. CollardChief Executive Officer2023-11-16150,000$0.92
$138.00kBuy
Ira DuarteEVP Chief Financial Officer2023-11-1685,000$0.89
$75.57kBuy
William P. ForbesEVP Chief Development Officer2023-11-1650,000$0.94
$47.00kBuy
Lisa PerazaVP Chief Accounting Officer2023-10-13860$0.72
$619.20Sell
Craig A. CollardChief Executive Officer2023-08-22692$1.65
$1.14kSell
Lisa PerazaVP Chief Accounting Officer2023-07-2514,743$1.51
$22.26kSell
Adam MorganDirector2023-07-212,486,744$1.37
$3.41MBuy

1 of 2

HRTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HRTX insiders and whales buy or sell their stock.

HRTX Shareholders

What type of owners hold Heron Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Spch LLC25.39%38,174,476$88.56MInsider
Rubric Capital Management LP17.77%26,713,503$61.98MInstitution
Rubric Capital Management LP17.77%26,713,503$61.98MInsider
Perceptive Advisors LLC17.74%26,666,667$61.87MInsider
Vanguard Group Inc5.55%8,338,912$19.35MInstitution
Blackrock Inc4.76%7,162,352$16.62MInstitution
Adam Morgan4.68%7,038,571$16.33MInsider
Velan Capital Investment Management LP4.65%6,986,744$16.21MInstitution
Franklin Resources Inc4.26%6,404,795$14.86MInstitution
Clearline Capital LP4.04%6,068,554$14.08MInstitution

1 of 3

HRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HRTX48.56%51.44%Net BuyingNet Selling
PGEN25.15%73.06%Net BuyingNet Selling
NAUT40.64%59.36%Net BuyingNet Buying
CTMX48.20%30.89%Net BuyingNet Buying
OCGN10.16%11.93%Net Selling
View Top Biotech Stocks

Heron Therapeutics Stock Ownership FAQ

Who owns Heron Therapeutics?

Heron Therapeutics (NASDAQ: HRTX) is owned by 74.74% institutional shareholders, 79.17% Heron Therapeutics insiders, and 0.00% retail investors. Spch LLC is the largest individual Heron Therapeutics shareholder, owning 38.17M shares representing 25.39% of the company. Spch LLC's Heron Therapeutics shares are currently valued at $89.33M.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.